Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIRIUS: SBRT + Systemic Therapy in mCRC
NCT05375708Phase 2Suspended
- Start
- Dec 2025
- Primary completion
- Jun 2031
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in metastatic colorectal cancer (mCRC) (2 arms). Primary endpoint: Progression-free survival at 24 months. Started Dec 2025; status: suspended.
02
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05375708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05375708.